2023
DOI: 10.3390/biology12091269
|View full text |Cite
|
Sign up to set email alerts
|

Literature-Based Discovery to Elucidate the Biological Links between Resistant Hypertension and COVID-19

David Kartchner,
Kevin McCoy,
Janhvi Dubey
et al.

Abstract: Multiple studies have reported new or exacerbated persistent or resistant hypertension in patients previously infected with COVID-19. We used literature-based discovery to identify and prioritize multi-scalar explanatory biology that relates resistant hypertension to COVID-19. Cross-domain text mining of 33+ million PubMed articles within a comprehensive knowledge graph was performed using SemNet 2.0. Unsupervised rank aggregation determined which concepts were most relevant utilizing the normalized HeteSim sc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
7
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3
1

Relationship

3
1

Authors

Journals

citations
Cited by 4 publications
(7 citation statements)
references
References 158 publications
0
7
0
Order By: Relevance
“…A total of 20 nodes were specified as “hub nodes” for making the hub node networks. Briefly, hub networks enable improved cross-domain analysis by functionally increasing the search depth in areas of the knowledge graph of chief interest [8, 14]. Ten pairwise simulation trials were performed, equating to 200 simulations.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…A total of 20 nodes were specified as “hub nodes” for making the hub node networks. Briefly, hub networks enable improved cross-domain analysis by functionally increasing the search depth in areas of the knowledge graph of chief interest [8, 14]. Ten pairwise simulation trials were performed, equating to 200 simulations.…”
Section: Methodsmentioning
confidence: 99%
“…The unsupervised learning ranking algorithm within SemNet 2.0 examines relationship patterns in the literature to rank cross-domain concepts with respect to the user-defined concept(s) [9]. SemNet 2.0 has been used for drug repurposing of COVID-19 [12] and Parkinson’s disease [13], to identify unknown disease mechanisms of resistant hypertension following COVID-19 infection [14], and to predict adverse events from chronic tyrosine kinase inhibitor therapy in chronic myeloid leukemia [8].…”
Section: Introductionmentioning
confidence: 99%
“…SemNet 2.0 uses the Unified Medical Language System (UMLS) as its ontology to specify concept types, such as pharmacological substances (PHSU); diseases or syndromes (DSYN) or biologically active substances (BAC); amino acids, peptides, and proteins (AAPP); genes or genomes (GNGM), etc. LBD with SemNet has been very useful for drug repurposing in COVID-19 [ 40 ], ascribing mechanisms of resistant hypertension after COVID-19 infection [ 41 ], assessing the long-term effects of tyrosine kinase inhibitors in chronic myeloid leukemia [ 42 ], and drug repurposing for Parkinson’s disease [ 43 ].…”
Section: Methodsmentioning
confidence: 99%
“…The unsupervised learning ranking algorithm within SemNet 2.0 examines relationship patterns in the literature to rank cross-domain concepts with respect to the user-defined concept(s) [31]. SemNet 2.0 has been used for drug repurposing for COVID-19 [34] and Parkinson's disease [35], identifying unknown disease mechanisms of resistant hypertension following COVID-19 infection [36], predicting adverse events from chronic tyrosine kinase inhibitor therapy in chronic myeloid leukemia [29], and identifying clinical features by which to better stratify chemotherapy-related infection risk in pediatric acute leukemia [37].…”
Section: Introductionmentioning
confidence: 99%
“…Ephrin receptors make up the largest subgroup of the receptor tyrosine kinase family, which have a key role in vascular regulation. SemNet 2.0 has previously highlighted the role of tyrosine kinase pathways in resistant hypertension [36].…”
mentioning
confidence: 99%